BioLight Offers to Increase its Equity Stake in Micromedic

BioLight announced its intention to increase its equity stake in Micromedic, its subsidiary that manages the cancer diagnostic portfolio, through a private placement of Micromedic’s shares.

According to the terms disclosed, the private placement includes an offering of 5,253,486 Micromedic Ordinary Shares in consideration for NIS 0.27 per share (based on to the average closing price per share in the 10 trading days preceding the date of the offer), for a total consideration of approx. NIS 1,418,000.

Link to complete article

Link to Newsroom

Comments are closed.